Clinical Trial Update: Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers [Phase 2]

View source ↗

Summary

This entry reports an active Phase II clinical trial sponsored by H. Lee Moffitt Cancer Center studying modulation of intermediate endpoint biomarkers in former…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lung Disease

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Lung Diseases, Lung Cancer, Protection Against | Phase 2 | Status: ACTIVE_NOT_RECRUITING